Bicocca Open Archive

Logo unimib boa
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.669
EU - Europa 3.364
AS - Asia 1.370
OC - Oceania 12
AF - Africa 8
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.432
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.505
CN - Cina 692
DE - Germania 645
SE - Svezia 580
UA - Ucraina 505
IE - Irlanda 469
IT - Italia 338
RU - Federazione Russa 293
SG - Singapore 280
HK - Hong Kong 236
CA - Canada 162
GB - Regno Unito 161
FI - Finlandia 122
AT - Austria 95
VN - Vietnam 70
FR - Francia 63
IN - India 42
CZ - Repubblica Ceca 24
NL - Olanda 23
DK - Danimarca 17
TR - Turchia 14
ID - Indonesia 13
BE - Belgio 12
JP - Giappone 9
AU - Australia 6
NZ - Nuova Zelanda 6
IR - Iran 5
BG - Bulgaria 4
ES - Italia 4
BR - Brasile 3
EG - Egitto 3
LB - Libano 3
CO - Colombia 2
EU - Europa 2
GR - Grecia 2
IQ - Iraq 2
KR - Corea 2
MX - Messico 2
PT - Portogallo 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CM - Camerun 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
RO - Romania 1
TW - Taiwan 1
VE - Venezuela 1
Totale 13.432
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.381
Woodbridge 1.161
Fairfield 865
Houston 766
Jacksonville 565
Dublin 458
Chandler 456
Ashburn 411
Wilmington 363
Seattle 350
Dearborn 346
Cambridge 302
Frankfurt am Main 236
Hong Kong 235
Singapore 234
Princeton 225
New York 191
Nanjing 119
Altamura 108
Hangzhou 107
Beijing 101
Lachine 97
Milan 96
Lawrence 95
Vienna 91
Shanghai 87
Santa Clara 48
Nanchang 45
San Diego 39
Shenyang 32
Ottawa 31
Dong Ket 30
Hebei 29
Jiaxing 26
Brno 23
Andover 22
Norwalk 22
Toronto 22
Tianjin 21
Falls Church 20
Helsinki 20
Jinan 19
Guangzhou 18
Munich 17
Ningbo 17
Mountain View 16
London 15
Changsha 14
Fremont 14
Huizen 14
Boardman 13
Brussels 11
Hefei 10
Jakarta 10
Kunming 10
Chicago 9
Lissone 8
Moscow 8
Zhengzhou 8
Kilburn 7
San Mateo 6
Edmonton 5
Lappeenranta 5
Montréal 5
Redmond 5
Rome 5
Taizhou 5
Turin 5
Nürnberg 4
Phoenix 4
San Francisco 4
University Park 4
Auburn Hills 3
Auckland 3
Bari 3
Campodarsego 3
Cincinnati 3
Dallas 3
Groningen 3
Hanoi 3
Jaipur 3
Kiev 3
Laurel 3
Leawood 3
Linköping 3
Los Angeles 3
Messina 3
Monmouth Junction 3
Sofia 3
Virginia Beach 3
Zanjan 3
Adelaide 2
Baotou 2
Basra 2
Beirut 2
Bologna 2
Bonndorf 2
Changchun 2
Chiswick 2
Clearwater 2
Totale 10.246
Salva come PNG Salva come JPEG
Nome #
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 288
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 240
Dyspnea in crackling lungs 213
Impact of traffic-related air pollution on pulmonary oxidative stress 198
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 194
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 189
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 181
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 180
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 178
A 61-year-old female with chronic cough and purulent sputum 174
Mixed community-acquired lower respiratory tract infections 169
A 13-year-old female with shortness of breath and pleuritic chest pain 168
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 167
Clinical phenotypes in adult patients with bronchiectasis 166
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 163
Prulifloxacin: A brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 161
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 157
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 155
Hospital admission decision for patients with community-acquired pneumonia 155
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 155
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia 149
Chlamydia pneumoniae and acute aortic syndrome: A call for a multi-institutional study 148
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 142
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 141
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 137
Strategic targets of essential host-pathogen interactions 136
Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines 136
The management of community-acquired pneumonia in the elderly 136
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 136
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF 135
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia 135
Pneumonia: how important are local epidemiology and smoking habits? 134
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 133
Compliance with anti-H1N1 vaccine among healthcare workers and general population 132
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 132
COPD and bronchiectasis: Phenotype, endotype or co-morbidity? 130
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 130
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 129
Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? 128
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 128
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study 128
100 years of respiratory medicine: pneumonia 126
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia 126
Impact of exacerbations in the natural course of COPD 126
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 126
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 126
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 125
Noninvasive ventilation or continuous positive airway pressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates 125
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 125
The bronchiectasis severity index. An international derivation and validation study 125
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 124
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 124
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 123
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 123
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection 122
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia 119
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 118
Early application of non-invasive continuous positive airway pressure in acute respiratory distress syndrome due to a drug overdose: a case report 118
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 118
Antibiotics as immunomodulant agents in COPD 118
The role of biomarkers in low respiratory tract infections 118
Validation of the 3CPO-score in a prospective cohort of Acute Cardiogenic Pulmonary Edema (ACPE) patients 117
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? 117
Azithromycin and lower respiratory tract infections 116
Do prognostic factors help physicians in predicting legionellosis' respiratory complications? 115
Where are the acutely ill best cared for and who should look after them? 114
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores 114
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 114
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): a two year study 113
Pneumococcal Vaccine and Patients with Pulmonary Diseases 113
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 112
The management of patients with community-acquired pneumonia beyond antibiotic therapy 112
Acute exacerbation of COPD: application of evidence-based guidelines 111
Individualizing duration of antibiotic therapy in community-acquired pneumonia 111
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 111
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 110
Chlamydophila pneumoniae 109
Management of nontuberculous mycobacterial infection in the elderly 107
Cardiac diseases complicating community-acquired pneumonia 106
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 105
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia 104
Is it time for a "pneumo-geriatrician" for frail old patients with respiratory diseases? 103
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia 102
Telithromycin in lower respiratory tract infections 100
Chlamydia pneumoniae and Mycoplasma pneumoniae 100
Clinical applications of azithromycin microspheres in respiratory tract infections 100
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia 99
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia 99
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia 95
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 93
Healthcare-associated pneumonia: where do we go next? 91
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 89
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 89
Non-invasive-ventilation in H1N1 acute respiratory failure in emergency department: A case series 89
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia 89
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 87
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective 86
Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial 84
“Normotension” on admission to the emergency department affects outcome of patients with acute cardiogenic pulmonary edema (ACPE) 82
The changing microbiologic epidemiology of community-acquired pneumonia 81
Totale 12.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.065 0 0 0 223 266 332 375 220 288 118 175 68
2020/20211.586 134 84 165 168 108 82 145 139 146 219 69 127
2021/20221.059 51 102 104 90 52 103 55 61 64 86 93 198
2022/20231.833 250 532 224 133 92 315 9 90 133 4 25 26
2023/20241.249 35 32 47 31 172 335 254 57 153 15 10 108
2024/2025637 205 348 76 8 0 0 0 0 0 0 0 0
Totale 13.659